Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hodson

Showing results (381-390 of 393) with videos related to

Pageof 40
Sort By:
Blood Advances|August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphomaFindlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Nature Genetics|July 31, 2025
Author Correction: The long-term effects of chemotherapy on normal blood cellsEmily Mitchell, My H Pham, Anna Clay, et al.
Nature Genetics|July 2, 2025
The long-term effects of chemotherapy on normal blood cellsEmily Mitchell, My H Pham, Anna Clay, et al.
Cell Reports|May 18, 2023
Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cellsWeiwei Xu, M M Fahd Qadir, Daniela Nasteska, et al.
Molecular Cancer|April 21, 2026
Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomasJon Celay, Miriam Recalde, Maria V Revuelta, et al.
Molecular Cell|August 26, 2021
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesisChun Gong, Joanna A Krupka, Jie Gao, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Science Immunology|August 12, 2022
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with <i>TRAF3</i> mutationsWilliam Rae, John M Sowerby, Dorit Verhoeven, et al.
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Pageof 40

Showing results (381-390 of 393) with videos related to

Sort By:
Pageof 40
Blood Advances|August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphomaFindlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Nature Genetics|July 31, 2025
Author Correction: The long-term effects of chemotherapy on normal blood cellsEmily Mitchell, My H Pham, Anna Clay, et al.
Nature Genetics|July 2, 2025
The long-term effects of chemotherapy on normal blood cellsEmily Mitchell, My H Pham, Anna Clay, et al.
Cell Reports|May 18, 2023
Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cellsWeiwei Xu, M M Fahd Qadir, Daniela Nasteska, et al.
Molecular Cancer|April 21, 2026
Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomasJon Celay, Miriam Recalde, Maria V Revuelta, et al.
Molecular Cell|August 26, 2021
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesisChun Gong, Joanna A Krupka, Jie Gao, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Science Immunology|August 12, 2022
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with <i>TRAF3</i> mutationsWilliam Rae, John M Sowerby, Dorit Verhoeven, et al.
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Pageof 40